Strides Arcolab gets USFDA approval; stock gains

Strides Arcolab has received US FDA approval for Idarubicin Injection, reports CNBC-TV18.

At 09:27 hrs Strides Arcolab was quoting at Rs 906, up Rs 9.40, or 1.05%. It has touched an intraday high of Rs 907.00 and an intraday low of Rs 894.
 
It was trading with volumes of 5,876 shares. In the previous trading session, the share closed up 0.78% or Rs 6.90 at Rs 896.60.
 
The share touched its 52-week high Rs 958.10 and 52-week low Rs 374.00 on 10 September, 2012 and 18 October, 2011, respectively.
 
Currently, it is trading 5.44% below its 52-week high and 142.25% above its 52-week low.
 
Market capitalisation stands at Rs 5,321.73 crore.

Anda sedang membaca artikel tentang

Strides Arcolab gets USFDA approval; stock gains

Dengan url

https://olahragakecantikan.blogspot.com/2012/10/strides-arcolab-gets-usfda-approval.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Strides Arcolab gets USFDA approval; stock gains

namun jangan lupa untuk meletakkan link

Strides Arcolab gets USFDA approval; stock gains

sebagai sumbernya